Company intelligence / Profile preview

Sunvold Technology

Ownership: Private
Development stage: Commercial

Overview

Sunvold Technology develops and commercializes innovative microbiome-based supplements aimed at improving pet health. Their products incorporate postbiotic and other advanced microbial technologies to enhance canine wellness. The company also holds a trademark application for a hair-growth supplement targeting rabbits. No human clinical results reported.

Therapeutic areas: OtherDermatologyGastroenterology
Modalities: Small moleculeMicrobiome-based supplementPostbiotic therapy
Industry: Veterinary

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Sunvold Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunvold Technology.

Explore the full profile